查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1788305

全球肺支架市场

Pulmonary Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球肺支架市场规模将达到 3.311 亿美元

全球肺支架市场规模预计在2024年达到2.488亿美元，预计2024年至2030年期间的复合年增长率为4.9%，到2030年将达到3.311亿美元。自动扩张型支架是本报告分析的细分市场之一，预计其复合年增长率为5.8%，到分析期结束时规模将达到2.215亿美元。球囊扩张型支架细分市场在分析期间的复合年增长率预计为3.2%。

美国市场规模估计为 6,540 万美元，中国市场预计复合年增长率为 4.7%

美国肺支架市场规模预计在2024年达到6,540万美元。作为世界第二大经济体，中国预计到2030年市场规模将达到5,320万美元，在2024-2030年的分析期间内，复合年增长率为4.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率分别为4.6%和4.2%。在欧洲，预计德国的复合年增长率为3.9%。

全球肺支架市场－主要趋势与驱动因素摘要

为什么肺支架在呼吸医学中变得不可或缺？

肺支架在治疗气管支气管狭窄、肺癌、慢性阻塞性肺病(COPD) 和术后併发症等引起的气道阻塞方面发挥关键作用。这些支架有助于保持呼吸道通畅性，使患者呼吸更顺畅，提高他们的整体生活品质。随着环境污染、吸烟和人口老化导致呼吸系统疾病的盛行率持续上升，对肺支架的需求正在显着增长。与侵入性外科手术不同，支气管镜支架置入术提供了一种微创解决方案，可缩短患者復原时间和住院时间。呼吸护理中对非手术治疗方法的日益增长的偏好推动了肺支架技术的进步，从而导致了更有效、更耐用和生物相容性的支架的开发。医疗保健提供者越来越多地将肺支架纳入治疗复杂气道疾病的治疗通讯协定中，全球医院和专科诊所越来越多地采用肺支架。

技术进步如何提升肺支架的性能？

肺支架设计和材料的最新创新已显着提高其临床疗效和患者预后。传统的金属和硅胶支架已得到改进，可最大限度地降低移位风险并提高气道内的长期稳定性。自动扩张型支架的引入，可贴合气道轮廓，减少频繁重新定位的需要，提高了手术成功率。此外，已开发出涂有抗发炎和抗增殖剂的药物释放型支架，以防止血管再阻塞并降低重复干预的可能性。生物可吸收支架会随着时间的推移逐渐溶解，已成为临时气道支持的一种有前途的选择，无需进行支架移除手术。此外，高解析度电脑断层扫描和引导支气管镜检查等影像技术的改进，提高了支架放置的准确性，减少了併发症并优化了治疗结果。随着正在进行的研究集中在提高支架的灵活性、生物相容性和长期疗效，下一代肺支架有望为呼吸医学树立新的标准。

哪些因素推动了肺支架的采用？

肺部疾病的日益普及和人们对微创治疗方案认识的不断提高，推动了对肺支架的需求。与传统的开放性手术相比，患者和医疗保健提供者更青睐支气管镜支架置入术，因为其风险更低、恢復更快、患者舒适度更高。肺癌发生率的上升，尤其是在老龄化社会中，进一步加速了对呼吸道管理解决方案的需求，肺支架广泛用于晚期癌症患者的姑息治疗。此外，由于空气污染和吸烟习惯，全球慢性阻塞性肺病 (COPD) 患者数量不断增加，导致需要植入支架以有效管理气道阻塞的情况增加。支架製造技术的进步，例如结合金属和硅胶优点的混合设计，由于其耐用性和功能性的提高，也促进了市场成长。许多已开发国家对肺部干预的报销政策进一步鼓励医院和专科诊所采用这些设备进行呼吸道管理。

推动肺支架市场成长的关键因素有哪些？

全球肺支架市场的成长受到多种关键因素的推动，包括慢性呼吸系统疾病盛行率的上升、支架设计和材料的进步，以及微创呼吸道管理技术的日益普及。医疗保健基础设施的扩张，尤其是在新兴市场，正在改善先进呼吸治疗的可及性，并推动对肺支架的需求。人工智慧影像处理和机器人支气管镜的整合也提高了手术的准确性，使支架置入更加有效，并降低了併发症率。此外，医疗机构、研究机构和医疗设备製造商对呼吸照护的投入不断增加，正在加速肺支架技术的创新。下一代支架的监管核准，以及医疗设备製造商和医疗机构之间日益增多的合作，正在进一步推动市场扩张。随着对有效呼吸道管理解决方案的需求持续增长，肺支架市场有望持续扩张，其持续的进步将塑造呼吸护理的未来。

部分

产品（自动扩张型支架、球囊扩张型支架）、材质（金属、硅胶、混合）、型式（气管支气管支架、喉头支架）

受访公司范例

  • Abbott
  • B. Braun Melsungen AG
  • Bayer AG
  • Bess Medizintechnik GmbH
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.（Cordis）
  • Cook Group
  • E. Benson Hood Laboratories, Inc.
  • EFER ENDOSCOPY
  • ENDO-FLEX GmbH
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • MI Tech
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Micro-Tech（Nanjing）Co., Ltd.

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP32727

Global Pulmonary Stents Market to Reach US$331.1 Million by 2030

The global market for Pulmonary Stents estimated at US$248.8 Million in the year 2024, is expected to reach US$331.1 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Self-expandable Stents, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$221.5 Million by the end of the analysis period. Growth in the Balloon-expandable Stents segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$65.4 Million While China is Forecast to Grow at 4.7% CAGR

The Pulmonary Stents market in the U.S. is estimated at US$65.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$53.2 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Pulmonary Stents Market - Key Trends & Drivers Summarized

Why Are Pulmonary Stents Becoming Essential in Respiratory Medicine?

Pulmonary stents play a crucial role in managing airway obstruction caused by conditions such as tracheobronchial stenosis, lung cancer, chronic obstructive pulmonary disease (COPD), and post-surgical complications. These stents help maintain airway patency, allowing patients to breathe more easily and improving overall quality of life. As the prevalence of respiratory disorders continues to rise due to environmental pollution, smoking, and aging populations, the demand for pulmonary stents has grown significantly. Unlike invasive surgical procedures, stent placement via bronchoscopy offers a minimally invasive solution, reducing patient recovery time and hospital stays. The increasing preference for non-surgical interventions in respiratory care has driven advancements in pulmonary stent technology, making them more effective, durable, and biocompatible. Healthcare providers are increasingly incorporating pulmonary stents into treatment protocols to manage complex airway diseases, leading to expanded adoption across hospitals and specialty clinics worldwide.

How Are Technological Advancements Improving Pulmonary Stent Performance?

Recent innovations in pulmonary stent design and materials have significantly enhanced their clinical efficacy and patient outcomes. Traditional metal and silicone stents have been refined to minimize migration risks and improve long-term stability within the airways. The introduction of self-expanding stents, which adapt to airway contours and reduce the need for frequent repositioning, has improved procedural success rates. Furthermore, drug-eluting pulmonary stents, coated with anti-inflammatory or anti-proliferative agents, are being developed to prevent restenosis and reduce the likelihood of repeat interventions. Bioresorbable stents, which gradually dissolve over time, are emerging as a promising alternative for temporary airway support, eliminating the need for stent removal procedures. Enhanced imaging technologies such as high-resolution CT scans and guided bronchoscopy have also improved the precision of stent placement, reducing complications and optimizing treatment outcomes. As research continues to focus on improving stent flexibility, biocompatibility, and long-term efficacy, the next generation of pulmonary stents is expected to set new standards in respiratory medicine.

What Factors Are Driving the Adoption of Pulmonary Stents?

The increasing prevalence of lung diseases, coupled with rising awareness about minimally invasive treatment options, has fueled the demand for pulmonary stents. Patients and healthcare providers are favoring bronchoscopic stenting over traditional open surgeries due to lower risks, faster recovery times, and improved patient comfort. The rising incidence of lung cancer, particularly in aging populations, has further accelerated the need for airway management solutions, with pulmonary stents being widely used for palliative care in advanced-stage cancer patients. Additionally, the growing number of COPD cases worldwide, driven by air pollution and smoking habits, has led to increased stent placements to manage airway obstruction effectively. Technological advancements in stent manufacturing, such as hybrid designs that combine the benefits of metal and silicone, are also contributing to market growth by offering enhanced durability and functionality. The availability of reimbursement policies for pulmonary interventions in many developed countries is further encouraging hospitals and specialty clinics to adopt these devices for airway management.

What Are the Key Drivers Fueling Growth in the Pulmonary Stents Market?

The growth in the global pulmonary stents market is driven by several key factors, including the rising incidence of chronic respiratory diseases, advancements in stent design and materials, and the increasing adoption of minimally invasive airway management techniques. The expansion of healthcare infrastructure, particularly in emerging markets, is improving access to advanced respiratory treatments, boosting demand for pulmonary stents. The integration of AI-powered imaging and robotic-assisted bronchoscopy is also enhancing procedural accuracy, making stent placement more effective and reducing complication rates. Furthermore, the growing investment in respiratory care by healthcare providers, research institutions, and medical device manufacturers is accelerating innovation in pulmonary stent technology. Regulatory approvals for next-generation stents, along with increasing collaborations between medical device companies and healthcare organizations, are further driving market expansion. As the demand for effective airway management solutions continues to grow, the pulmonary stents market is poised for sustained development, with ongoing advancements shaping the future of respiratory care.

SCOPE OF STUDY:

The report analyzes the Pulmonary Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Self-expandable Stents, Balloon-expandable Stents); Material (Metal, Silicon, Hybrid); Type (Tracheobronchial Stents, Laryngeal Stents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott
  • B. Braun Melsungen AG
  • Bayer AG
  • Bess Medizintechnik GmbH
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc. (Cordis)
  • Cook Group
  • E. Benson Hood Laboratories, Inc.
  • EFER ENDOSCOPY
  • ENDO-FLEX GmbH
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • M.I. Tech
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Micro-Tech (Nanjing) Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Pulmonary Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Tracheobronchial Obstructions and Airway Stenosis Throws the Spotlight on Pulmonary Stent Utilization
    • Expansion of Interventional Pulmonology and Minimally Invasive Airway Management Drives Adoption of Pulmonary Stents
    • Increasing Prevalence of COPD, Lung Cancer, and Post-Intubation Stenosis Strengthens Business Case for Airway Stenting
    • Advancements in Stent Design, Flexibility, and Radial Force Propel Innovation in Customized Pulmonary Stents
    • Surge in Geriatric Population and Age-Related Respiratory Disorders Drives Demand for Long-Term Airway Patency Solutions
    • Development of Drug-Eluting and Bioabsorbable Pulmonary Stents Expands the Therapeutic Scope for Chronic Pulmonary Conditions
    • Rising Adoption of 3D Printing and Patient-Specific Stent Models Enhances Procedural Precision and Clinical Outcomes
    • Integration of Bronchoscopic Navigation and Imaging Systems Improves Placement Accuracy and Procedural Safety
    • Growing Use of Temporary and Removable Silicone Stents Spurs Preference for Less Invasive and Reversible Airway Interventions
    • Regulatory Approvals and Reimbursement Policies Supporting Interventional Pulmonary Devices Propel Market Penetration
    • Increased Focus on Airway Rescue and Palliative Interventions in Advanced-Stage Oncology Boosts Pulmonary Stent Procedures
    • Emergence of Customized Hybrid Stents Combining Metal and Polymer Components Enhances Functional Performance
    • Collaborations Between Pulmonologists and Thoracic Surgeons Drive Adoption of Multidisciplinary Airway Management Approaches
    • Expansion of Specialized Centers for Complex Airway Disorders Spurs Training and Procedural Volumes Globally
    • Surging Demand for Pediatric Airway Stents Creates Opportunities for Miniaturized and Growth-Adaptive Device Designs
    • Focus on Reducing Granulation Tissue Formation and Migration Complications Drives Next-Generation Stent Development
    • Growth of Ambulatory Bronchoscopy Services Accelerates Use of Pulmonary Stents in Outpatient Settings
    • Rising Use of Pulmonary Stents in Emergency Airway Obstruction Scenarios Fuels Demand for Rapid-Deployment Systems
    • Investment in Clinical Trials and Real-World Evidence Collection Strengthens Regulatory Support and Market Confidence
    • Integration of Pulmonary Stents with Adjunctive Therapies Like Radiation and Chemotherapy Expands Multimodal Treatment Models
    • Expansion into Emerging Markets with Rising Respiratory Disease Burden Sustains Global Demand for Pulmonary Stenting Solutions
    • Focus on Sustainable Manufacturing and Biocompatible Materials Supports Eco-Efficient and Patient-Centric Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pulmonary Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Self-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Self-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Balloon-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Balloon-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Metal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Silicon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Silicon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Tracheobronchial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Tracheobronchial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Laryngeal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Laryngeal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • JAPAN
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • CHINA
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • EUROPE
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • FRANCE
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • GERMANY
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • UNITED KINGDOM
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030

IV. COMPETITION